The Collaborative Eclampsia Trial 18
| Complications | Magnesium sulphate (%) | Diazepam (%) | Significance | Magnesium sulphate (%) | Phenytoin (%) | Significance |
|---|---|---|---|---|---|---|
| NS = non-significant, S = significant. | ||||||
| Recurrent fits | 13.2 | 27.9 | S | 5.7 | 17.1 | S |
| Maternal mortality | 3.8 | 5.1 | NS | 2.6 | 5.2 | NS |
| Perinatal mortality | 24.8 | 22.4 | NS | 26.1 | 30.7 | NS |
| Ventilation | 5.5 | 6.0 | NS | 14.9 | 22.5 | S |
| Respiratory depression | 7.7 | 7.3 | NS | 8.2 | 11.6 | NS |
| Pneumonia | 2.0 | 3.1 | NS | 3.9 | 8.8 | S |
| ITU admission | 14.3 | 16.6 | NS | 16.7 | 25.1 | S |
| Blood transfusion | 15.1 | 20.1 | NS | 19.7 | 27.0 | S |
| Neonatal intubation | 11.3 | 15.7 | NS | 12.7 | 23.9 | S |
| SCBU admission | 46.5 | 50.2 | NS | 31.7 | 43.6 | S |